CARIS LIFE SCIENCES, INC. Payments of Stock Issuance Costs
CARIS LIFE SCIENCES, INC. (CAI) reported Payments of Stock Issuance Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for the quarter ending 2025-09-30 was $5.67M, a 945.20% increase year-over-year.
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for fiscal 2025 was $7.71M, a 628.05% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for fiscal 2024 was $1.06M.
- CARIS LIFE SCIENCES, INC. payments of stock issuance costs for fiscal 2023 was $0.00.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $5.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $5.67M derived: sum of 3 quarters · filed 2026-05-08 | $7.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.67M derived: sum of 2 quarters · filed 2026-03-03 | $7.61M derived: sum of 3 quarters · filed 2026-08-05 | $7.71M 10-K · filed 2026-03-03 |
| 2025-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.61M derived: sum of 2 quarters · filed 2026-08-05 | $7.71M 10-Q · filed 2025-11-05 | $7.74M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.04M 10-Q · filed 2026-08-05 | $2.07M derived: sum of 3 quarters · filed 2026-08-05 | $2.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $105.00K 10-Q · filed 2026-05-08 | $130.00K derived: sum of 2 quarters · filed 2026-05-08 | $672.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $567.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.06M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.03M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $492.00K 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |